NAGE
Niagen Bioscience, Inc.
Next earnings Aug 4, 2026 · consensus $0.02 EPS, $32.3M rev
Last earnings +3.1% on 2026-05-06
$3.31
▼ -4.06%$3.31▼ -75.37%
over 1Y
L $3.31EODHDH $14.41
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-4.1%
1W-5.4%
1M-14.2%
3M-26.0%
YTD-47.0%
1Y-75.4%
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Revenue grew 29.9% YoY.
The read
Quality fundamentals and an attractive price line up (~130% below fair value) — the rarer case where both the business and the entry look good.
Sources: SEC EDGAR (CIK 0001386570, latest 10-Q filed 2026-05-06) · EODHD · as of 6/26/2026, 4:49:58 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.